Healthcare-Associated Infections in Older Adults: How Aging Immune Changes Affect Treatment, Nutrition, and Care

The first level of impairment concerns innate immune circuits, which constitute the initial barrier to HAIs [5]. With advancing age, the innate immune system undergoes profound remodeling, resulting in a paradoxical state of hyporesponsiveness to pathogens combined with chronic low-grade hyperinflammation [5]. This is reflected in attenuated Toll-like receptor (TLR) signaling and less efficient antigen presentation by dendritic cells (DCs) and monocytes [6]. Specifically, aged DCs and monocytes display reduced TLR-dependent reactivity, and stimulation of TLR7 and TLR9 results in diminished production of interferon-α (IFN-α) and interleukin-12 (IL-12), impairing antiviral and antibacterial responses as well as effective antibody production [7]. In parallel, antigen presentation capacity is compromised by reduced expression of major histocompatibility complex class II (MHC-II) and co-stimulatory molecules (CD80/CD86), along with attenuated cytokine secretion [8]. This leads to inefficient priming of cytotoxic T lymphocytes (CTLs) and T helper cells, thereby weakening adaptive immune responses [9].

Defective pathogen sensing and antigen presentation limit early immune activation, setting the stage for broader innate dysfunctions [10]. Neutrophils, which represent the first line of defense against bacterial and fungal pathogens, display impaired chemotaxis, reduced phagocytic capacity, and an attenuated oxidative burst, ultimately limiting their ability to contain infections and contributing to inappropriate tissue damage [10]. Similarly, natural killer (NK) cells undergo functional decline, with a progressive reduction in their cytotoxic activity and cytokine secretion, resulting in decreased clearance of virally infected and malignant cells [11]. In addition, the complement system becomes increasingly dysregulated, with excessive or misdirected activation that promotes the release of pro-inflammatory anaphylatoxins (C3a, C5a) and membrane attack complexes, thereby amplifying bystander inflammation and collateral tissue damage [12].

Collectively, these alterations contribute to a paradoxical state of immune senescence characterized by reduced antimicrobial defense on the one hand and chronic, low-grade inflammatory activity on the other. The net effect is delayed pathogen recognition, suboptimal microbial clearance, and excessive tissue damage, all of which contribute to the severity and persistence of HAIs, particularly in the presence of invasive devices [13]. These innate deficits set the stage for further impairment at the adaptive level [12].

Adaptive immunity is composed of T and B lymphocytes, responsible for cellular and humoral responses, respectively. With advancing age, this compartment undergoes profound modifications that compromise the efficiency of immune responses and increase the susceptibility of older adults to HAIs [14,15].

A key aspect of immunosenescence involves thymic involution. With aging, both the cortex and medulla of the thymus are progressively replaced by adipose tissue, leading to a drastic reduction in the production of naïve T lymphocytes. This reduction, which becomes evident as early as 40–54 years of age and is further accentuated in the 55–69- and 70–90 years age groups, limits the number of new T cells entering circulation and thus narrows the ability to respond to novel antigens [16].

In parallel, a decline is observed in the total number of T lymphocytes, their clonal diversity, and the intensity of intracellular signaling. The reduced diversity of the T cell receptor repertoire becomes particularly marked after the age of 65, significantly impairing the ability to recognize emerging pathogens. Phenotypically, aging is associated with a decrease in CD4+ T lymphocytes, an increase in CD8+ cells, and a progressive loss of CD28 expression, a crucial costimulatory molecule. This imbalance compromises IL-2 production and reduces the efficiency of T helper–B cell cooperation, resulting in diminished antibody production [17].

Immune homeostasis is further altered by the behavior of regulatory T cells (Tregs). Although their numbers increase with age, their functionality is reduced, resulting in a state of dysregulation that limits effective responses against new antigens while simultaneously favoring chronic inflammation [18]. The balance among T helper subsets is also profoundly affected: Th1 responses, critical for controlling intracellular pathogens, are weakened, whereas Th2 and Th17 responses tend to prevail, fueling a pro-inflammatory and dysfunctional state [19].

Imbalanced helper subsets and dysfunctional Treg activity exacerbate inflammation and reduce coordination with B cells [20]. In older adults, the clonal repertoire narrows and the ability to produce high-affinity antibodies is significantly reduced. Although total immunoglobulin levels may appear increased, the proportion of antigen-specific antibodies generated following antigen exposure is markedly lower [20].

Another critical mechanism involves impaired cooperation between follicular helper T cells (Tfh) and B cells, which is indispensable for germinal center organization and function. With aging, germinal center activity in lymph nodes and spleen becomes less efficient, resulting in reduced generation of long-lived plasma cells and memory B cells [21]. This deficit translates into diminished effectiveness of secondary responses, both against reinfections and in response to vaccination [22].

Moreover, age-related changes affect the expression of activation-induced cytidine deaminase (AID) and other enzymes crucial for class-switch recombination and somatic hypermutation. As a result, antibody affinity maturation is compromised, leading to a predominance of low-affinity IgM and reduced isotype switching toward IgG and IgA, both essential for mucosal and systemic defense [23]. These alterations not only weaken protection against novel pathogens but also reduce the effectiveness of vaccines specifically designed for older adults.

Recent studies further highlight an age-dependent expansion of so-called "age-associated B cells" (ABCs), a subset characterized by expression of CD11c and T-bet, which exhibit pro-inflammatory properties and reduced capacity to generate protective responses [24]. The accumulation of ABCs contributes to systemic inflammation and autoantibody production, adding another layer of dysregulation to the humoral immune system in older individuals.

In summary, the remodeling of the B-cell compartment during aging involves repertoire contraction, defective germinal center responses, impaired antibody maturation, and the emergence of dysfunctional subsets. Together with T-cell alterations, these changes profoundly limit both antigen recognition and the ability to mount durable and protective immune responses. Collectively, these mechanisms play a decisive role in the increased incidence and severity of HAIs in the elderly population [20,21,22,23].

Imbalanced helper subsets and dysfunctional Treg activity exacerbate inflammation and reduce coordination with B cells [20].

Subclinical inflammation emerges as a transversal amplifier of immunosenescence-related vulnerability [25]. "Inflammaging" represents a state of chronic, low-grade inflammation that progressively develops with advancing age, and is considered a hallmark of immune aging [25]. This condition significantly contributes to increasing the vulnerability of older adults to HAIs.

Several molecular mechanisms underlie this process. Among them, a central role is played by the persistent activation of the transcription factor NF-κB, a key regulator of inflammatory responses. In older individuals, its chronic activation results in sustained elevation of pro-inflammatory cytokines such as IL-6, TNF-α, and IL-1β, even in the absence of infectious stimuli [25].

With aging, there is also a progressive accumulation of senescent cells that acquire a SASP. This phenotype is characterized by the release of cytokines, chemokines, metalloproteinases, and growth factors that sustain the chronic inflammatory state. Although SASP initially exerts protective functions by promoting tissue repair and the clearance of damaged cells, its long-term persistence promotes immunosenescence and alters tissue microenvironments, favoring dysfunctional conditions [26].

Another relevant mechanism involves the progressive impairment of mitochondrial function. With age, a decline in respiratory efficiency is observed, accompanied by increased production of reactive oxygen species (ROS). Excessive ROS cause oxidative damage to DNA, proteins, and lipids, while simultaneously amplifying inflammatory responses through activation of NF-κB and the NLRP3 inflammasome [27]. Activation of the NLRP3 inflammasome promotes the maturation and release of IL-1β and IL-18, cytokines that perpetuate chronic low-grade inflammation. This pathway directly links mitochondrial dysfunction to inflammaging, creating a self-sustaining cycle of oxidative stress and immune dysregulation. In the context of HAIs, mitochondrial dysfunction and inflammaging converge to increase susceptibility by weakening antimicrobial defenses and impairing tissue repair. Chronic low-grade inflammation compromises the ability to mount effective immune responses against pathogenic microorganisms, thereby raising the risk of nosocomial infections. At the same time, the persistent inflammatory milieu delays wound healing and postoperative recovery, ultimately heightening the likelihood of infectious complications and overall clinical vulnerability in older hospitalized patients [23,27].

In summary, inflammaging represents a key component of immunosenescence: a persistent, subclinical inflammation that not only favors the onset and severity of HAIs but also compromises the reparative and regenerative capacity of the organism in older individuals [23].

Building on this chronic inflammatory background, age-related metabolic alterations further shape immune cell function, linking inflammaging to profound changes in immunometabolism, which focuses on the metabolic pathways that regulate immune cell activation, differentiation, and effector functions, and represents a fundamental determinant of host defense [28]. Aging profoundly alters these mechanisms, leading to a "metabolic rewiring" that, in close interaction with immunosenescence, contributes to the increased susceptibility of older adults to HAIs.

In elderly individuals, persistent hyperactivation of the mechanistic target of rapamycin (mTOR) pathway has been documented, together with reduced activation of AMP-activated protein kinase (AMPK). The mTOR pathway promotes anabolic processes and cellular growth, whereas AMPK supports catabolic pathways and adaptation to stress [28,29]. The imbalance in favor of mTOR results in chronic inflammation and reduced immune cell responsiveness to infectious stimuli, typical of hospital settings. While these pathways are increasingly recognized as targets for immunosenescence, their clinical translation is still preliminary. Most available data derive from animal models or indirect evidence from metabolic diseases, and large-scale trials in elderly inpatients are still lacking.

Autophagy and mitophagy that are essential for the clearance of damaged cellular components and for the maintenance of cellular homeostasis, are also impaired with aging [30,31]. Their inefficiency leads to the accumulation of dysfunctional mitochondria and increased production of ROS, which amplify oxidative stress, impair antigen presentation, and reduce the capacity of immune cells to eliminate intracellular microorganisms.

Metabolic rewiring also affects adaptive immunity. In naïve T cells, the ability to switch from oxidative metabolism to aerobic glycolysis during clonal expansion is impaired, leading to slower and less effective responses against hospital-acquired pathogens. In B lymphocytes, bioenergetic alterations hinder differentiation into plasma cells and the production of high-affinity antibodies, thereby reducing vaccine efficacy and protection against recurrent infections in hospitalized older adults. These changes not only impair antimicrobial responses but also alter tolerance mechanisms, promoting autoimmunity and chronic low-grade inflammation. Both aspects converge to increase the frequency, severity, and complexity of HAIs in this population [32].

The metabolic rewiring of immune cells in the elderly therefore represents not only a biological phenomenon but also a clinical determinant of immune frailty, and could explain the greater severity and higher risk of complications associated with HAIs in older adults.

The aging of the immune system is not solely determined by genetic factors but also by epigenetic modifications, namely changes in gene expression that occur without altering the DNA sequence. Among the key epigenetic determinants are lifestyle and environmental factors. These changes, which progressively accumulate over the course of life, substantially contribute to immunosenescence and to the increased susceptibility of older adults to HAIs [33]. It has been increasingly recognized that "successful" immune aging appears to rely less on strictly genetic determinants and more on the capacity to generate effective immune responses against pathogens, thereby mitigating cellular damage and tissue inflammation [34].

In this context, DNA methylation (DNAm) represents one of the most extensively studied epigenetic mechanisms. Methyl groups can be added to or removed from DNA, thereby regulating gene expression. With advancing age, this process undergoes a "drift" characterized by global hypomethylation and site-specific hypermethylation. Such alterations influence the expression of genes involved in lymphocyte proliferation and functionality, ultimately impairing immune responses. Notably, DNA methylation has been proposed as a biomarker of immunosenescence and of susceptibility to HAIs [35].

In addition to DNA, histones undergo a wide range of post-translational modifications, most notably acetylation and methylation, catalyzed by enzymes such as histone acetyltransferases (HATs), histone deacetylases (HDACs), and histone methyltransferases (DNMT). In older individuals, these epigenetic alterations promote the sustained activation of NF-κB–mediated inflammatory pathways, a defining feature of the "inflammaging" phenotype. This chronic pro-inflammatory state not only heightens susceptibility to hospital-acquired infections but also compromises tissue repair and regenerative capacity [36].

An additional layer of epigenetic regulation is represented by non-coding RNAs, particularly microRNAs (miRNAs) and long non-coding RNAs (lncRNAs). miRNAs, which play a pivotal role in regulating both innate and adaptive immune responses, display altered expression profiles in the elderly [37]. Their dysregulation impairs T-cell activation and diminishes the organism's ability to mount effective defenses against novel infections. Similarly, specific lncRNAs modulate the transcription of genes essential for immune homeostasis and, when altered, contribute to the establishment of a chronic inflammatory state [37]. Epigenetic alterations also directly affect the efficiency of antimicrobial responses. DNA methylation and histone modifications regulate, for example, the expression of pathogen recognition receptors (PRRs), antimicrobial molecules, and mediators of innate immunity. With advancing age, the dysregulation of these mechanisms contributes to a diminished capacity to eliminate pathogens and to increased severity of nosocomial infections [38].

In summary, epigenetic modifications represent a crucial component of the immunosenescence process. By modulating inflammatory and antimicrobial circuits, and interacting with other mechanisms of immune aging, they help explain the high incidence and severity of HAIs in the elderly population [39].

Age-related dysbiosis integrates with immunosenescence to amplify infection risk. Aging is associated with marked alterations in microbial ecology, including reduced alpha diversity, loss of key short-chain fatty acid (SCFA) producers such as Faecalibacterium prausnitzii and Roseburia spp., and an overgrowth of opportunistic Enterobacterales [40]. These compositional shifts impair epithelial barrier integrity, decrease local SCFA availability, and promote a pro-inflammatory milieu that predisposes to pathogen overgrowth and translocation. Hospital-related factors including dietary restrictions, polypharmacy, multimorbidity, and cumulative exposure to broad-spectrum antibiotics, further exacerbate this dysbiotic state. The result is a permissive niche for colonization by Clostridioides difficile, ESBL-producing Enterobacteriaceae, carbapenem-resistant Klebsiella pneumoniae, and vancomycin-resistant Enterococcus faecium (VRE), which significantly increases the incidence and severity of HAIs in the elderly [41,42]. In institutionalized elderly patients, reduced microbial diversity has been associated with a higher incidence of bacteremia and an increased risk of Clostridioides difficile infections, particularly following hospital-based antibiotic therapies. [43].

One of the most critical consequences of age-related gut microbiota alterations is the reduced production of SCFAs, particularly butyrate, acetate, and propionate. These metabolites are essential not only for maintaining epithelial barrier integrity but also for immune regulation through mechanisms such as activation of G-protein–coupled receptors (e.g., GPR41, GPR43) and inhibition of HDACs. These pathways promote the differentiation and function of Tregs and support mucosal immune tolerance. SCFA deficiency therefore disrupts epithelial homeostasis, impairs Treg-mediated control of inflammation, and amplifies pro-inflammatory responses, creating a permissive environment for hospital-acquired pathogens and predisposing to recurrent Clostridioides difficile infection [44]. Several studies have also highlighted that SCFA-deficient microbial profiles are associated with decolonization failures and a high likelihood of reinfections, thereby complicating the clinical course of hospitalized older adults [45].

Concomitantly, aging induces significant structural alterations of the intestinal mucosa. Impairment of tight junctions, reduced mucus secretion, and defective epithelial regeneration collectively contribute to the "leaky gut" phenotype, characterized by increased intestinal barrier permeability. This condition facilitates the translocation of lipopolysaccharides (LPS) and other pathogen-associated molecular patterns (PAMPs), driving chronic endotoxemia and the activation of inflammatory pathways such as NF-κB and NLRP3 [46]. Both clinical and experimental evidence confirm that these mechanisms are strongly associated with an increased incidence of enteric-derived bacteremia, episodes of sepsis, and a more severe clinical course, particularly in the context of polypharmacy and pronounced dysbiosis [46].

Intestinal dysbiosis further amplifies the phenomenon of inflammaging, sustaining a chronically inflamed yet paradoxically inefficient mucosal microenvironment that fails to control pathogens effectively [47]. Continuous input of LPS together with the deficiency of metabolites such as SCFAs promotes persistent colonization by multidrug-resistant microorganisms, including VRE, ESBL-producing Enterobacteriaceae, and carbapenem-resistant Enterobacteriaceae (CRE), leading to a marked increase in the incidence and severity of HAIs [48]. Within this context, prolonged hospitalization acts as an additional amplifier, closing a vicious cycle that renders older adults particularly vulnerable to HAIs [49]. Recent "microbiota-directed" strategies are opening new therapeutic perspectives. Fecal microbiota transplantation (FMT), already implemented successfully in several specialized centers, has been shown to significantly reduce Clostridioides difficile recurrences and to partially restore colonization resistance against MDR pathogens, outlining a promising preventive and therapeutic approach for HAIs [50]. In summary, the progressive dysbiosis that accompanies aging represents a key determinant of immune frailty in older adults. The combination of reduced microbial diversity, SCFA deficiency, impaired intestinal barrier function, and enhanced inflammaging convincingly explains the increased susceptibility to HAIs, the higher frequency of persistent colonization, and the greater severity of nosocomial infections observed in the geriatric population.

The key molecular mechanisms of immunosenescence, their functional consequences, and their impact on HAIs in older adults are detailed in Table 1.

Translating molecular mechanisms into clinical contexts highlights modifiable determinants of infection risk. Adequate nutrition is a fundamental requirement for maintaining full immune competence in older adults and represents a cornerstone in the prevention and control of nosocomial infections [51]. Deficiencies in essential nutrients, particularly protein-energy malnutrition, together with sarcopenia, comorbidities, microbiota alteration and polypharmacy, collectively impair the integrity of host defense barriers and facilitate colonization by MDROs [52]. This combination of factors significantly increases the risk of HAIs and worsens clinical outcomes.

Protein-energy malnutrition is highly prevalent among hospitalized older adults, with reported rates ranging from 12% to 50% [53]. This impairment leads to a reduction in protein synthesis, which is indispensable for the production of cytokines and antibodies, thereby compromising both innate and adaptive immune responses [54]. As a result, the immune system undergoes progressive weakening, with impaired T- and B-cell function and consequent compromise of both innate and adaptive immunity, and predisposes older adults to heightened vulnerability to HAIs [23].

A direct consequence of malnutrition is often sarcopenia, defined as the progressive loss of muscle mass, strength, and function. This condition, which is highly common in the geriatric population, leads to a reduced availability of essential amino acids necessary to sustain the inflammatory response and gluconeogenesis [55].

Several observational studies and meta-analyses have demonstrated that both malnutrition and sarcopenia are independent risk factors for sepsis and nosocomial infections, particularly pneumonia, urinary tract infections, surgical site infections, and stroke-associated infections (SAI). For instance, in a large cohort of older patients with acute ischemic stroke, pre-stroke sarcopenia risk was independently associated with a significantly higher incidence of pneumonia and urinary tract infections during hospitalization [56]. In another study of elderly patients hospitalized with community-acquired pneumonia, malnutrition was linked not only to longer hospital stays and higher readmission rates, but also increased in-hospital mortality [57]. Collectively, these findings underscore malnutrition and sarcopenia as independent contributors to immune frailty and adverse outcomes in geriatric inpatients.

Polypharmacy, commonly defined as the concomitant use of five or more medications, is a hallmark of geriatric care and exerts multifaceted effects on host–microbiota–immune interactions [58]. Several pharmacological classes frequently prescribed in older adults including antibiotics, proton pump inhibitors, nonsteroidal anti-inflammatory drugs, psychotropics, and antidiabetics have been demonstrated to profoundly alter intestinal microbial diversity and metabolic capacity [58]. These drug-induced perturbations reduce the abundance of commensal, SCFA-producing taxa while facilitating the expansion of pathobionts, thereby impairing epithelial barrier integrity and promoting the systemic translocation of pathogen-associated molecular patterns such as lipopolysaccharides [59]. This dysbiotic milieu can contribute to "inflammaging" and accelerate immunosenescence. Some evidence link also chronic exposure to multiple pharmacological agents to a reduced vaccine immunogenicity [60].

Among specific examples, proton pump inhibitors have been shown to reproducibly alter gut microbial ecology and to predispose to Clostridioides difficile infection, further exemplifying the translational consequences of polypharmacy-induced dysbiosis [61].

Although direct studies linking polypharmacy with nosocomial infection rates in elderly inpatients are still limited, some observational studies show that polypharmacy is associated with higher incidence of pneumonia-related hospitalizations and worse clinical utilization metrics [62] and that hospitalised geriatric populations with high medication burdens present with more severe comorbidities and worse outcomes overall [63].

Collectively, polypharmacy emerges as a critical amplifier of immune frailty in the elderly, acting through intertwined mechanisms of microbiota disruption and direct immunomodulation.

Multimorbidity, a condition defined by the occurrence of two or more medical conditions, is no longer the exception but the rule in hospitalized older adults, and its implications for infection risk extend far beyond the simple addition of individual comorbidities [64]. Multimorbidity is associated per se with an increased risk of hospitalizations [65], and the coexistence of chronic conditions such as diabetes, chronic kidney disease, COPD, and heart failure generates a network of converging pathophysiological alterations such as persistent low-grade inflammation, impaired mucociliary clearance, endothelial dysfunction, metabolic dysregulation, and reduced leukocyte competence [66]. These factors do not act in isolation but reinforce each other, producing a state of "immune frailty" that markedly increases vulnerability to both community-acquired and nosocomial infections [66].

Importantly, the relationship between multimorbidity and infection is not linear but cumulative: each added chronic condition compounds the risk, amplifying susceptibility to pneumonia, urinary tract infections, sepsis, and Clostridioides difficile infection. In a retrospective study using the Cumulative Illness Rating Scale (CIRS), older inpatients with the highest multimorbidity burden had a more than fivefold increased risk of hospital-acquired C. difficile infection compared with those with lower scores [67]. Similarly, in a large multicenter cohort of older adults hospitalized with Omicron variant from SARS-CoV-2 infection, multimorbidity combined with functional decline was strongly predictive of progression to severe disease (OR ≈10) [68].

Taken together, these findings underscore that multimorbidity should not be regarded merely as background noise, but as a central determinant of infection trajectories in the elderly. Its synergistic impact with malnutrition, sarcopenia, and polypharmacy generates a self-perpetuating cycle of dysbiosis, inflammation, and immune decline, amplifying infection risk and adverse outcomes.

Nutritional management is fundamental in older inpatients, where malnutrition and sarcopenia are frequent and contribute to impaired host defenses. Systematic screening with validated tools such as the Mini Nutritional Assessment (MNA), Malnutrition Universal Screening Tool (MUST), or Controlling Nutritional Status (CONUT) score allows early identification of at-risk individuals, who should promptly receive tailored nutritional support [69,70,71].

MNA is specifically developed and validated for older adults, and combines anthropometric measures, dietary assessment, and global/subjective evaluation; the short form (MNA-SF) is widely used in hospitals and long-term care [69]. MUST is instead a practical five-step instrument that evaluates BMI, recent unintentional weight loss, and the anticipated impact of acute illness on dietary intake. It is easy to implement across a wide range of clinical settings and is widely recommended for routine nutritional risk screening in hospitalized patients [70]. Finally CONUT is a laboratory-based screening tool calculated from serum albumin, total lymphocyte count, and cholesterol, reflecting both nutritional and immune status, with strong prognostic value in hospitalized patients [71].

Core nutritional interventions generally include ensuring adequate caloric intake, providing high-quality proteins to help preserve lean body mass, and addressing deficiencies of key micronutrients such as vitamin D, zinc, and selenium. These nutrients are recognized as important cofactors in several immune processes and may contribute to maintaining host defense, although the evidence in older hospitalized populations remains limited [72,73]. However, in routine internal medicine wards, nutritional assessment is often underutilized and patients frequently receive standardized diets without individualized adjustments. This approach, while practical, may overlook specific deficits and, particularly during prolonged hospitalizations, can lead to significant caloric and protein inadequacies, thereby aggravating pre-existing malnutrition and further compromising immune resilience [74,75]

Among the available interventions, probiotics have been the most extensively studied. Administered as live microorganisms in adequate amounts, they have shown some promise in reducing infectious complications in frail older inpatients. For example, in a recent trial involving tube-fed elderly patients treated with antibiotics, probiotic supplementation reduced the frequency of diarrhea and improved overall tolerance [76]. Prebiotics, on the other hand, act by selectively stimulating beneficial microbial taxa such as SCFA-producing bacteria, thereby enhancing anti-inflammatory pathways; however, clinical evidence in hospitalized geriatric populations is still limited and largely exploratory [77]. A further step is represented by postbiotics, consisting of inactivated microorganisms or their structural components. These compounds appear particularly attractive in frail or immunocompromised patients, as they retain immunomodulatory properties without the risks associated with live bacteria [78].

In a systematic review, postbiotics derived from heat-inactivated Lactobacillaceae and Bifidobacteriaceae strains demonstrated anti-inflammatory properties through modulation of cytokine expression, reinforcement of epithelial barrier integrity, and regulation of immune cell signaling pathways. They were also shown to rebalance Th1/Th2 and Treg/Th17 responses, indicating potential applications in inflammatory bowel disease, autoimmune disorders, and metabolic syndrome. Nevertheless, considerable study heterogeneity and risk of bias warrant cautious interpretation of these findings [79].

The most established microbiota-directed strategy is fecal microbiota transplantation (FMT), which is considered an effective option for recurrent Clostridioides difficile infection, including in older adults, particularly when conventional pharmacological therapies fail. While FMT has shown sustained reductions in recurrence rates and, in selected studies, decreased MDRO carriage through restoration of colonization resistance, it remains a semi-invasive intervention that is not without logistical and safety considerations. Its use should therefore be viewed as complementary rather than a first-line approach, and further research is needed to better define its long-term efficacy and optimal patient selection [80].

Taken together, probiotics, prebiotics, postbiotics, and FMT illustrate different but complementary approaches to modulating the gut microbiota in elderly inpatients. While the evidence base is steadily growing, particularly for FMT, important gaps remain regarding strain specificity, dosing, long-term safety, and applicability in immunocompromised hosts. Well-designed trials targeting frail hospitalized populations are therefore essential to define the true role of microbiota-targeted therapies in infection prevention.

Epigenetic dysregulation is a recognized hallmark of aging and contributes to immune decline through altered gene expression, reduced lymphocyte diversity, and persistent low-grade inflammation. As mentioned above, pharmacological epigenetic modulators, including HDAC and DNMT inhibitors, have been explored in preclinical models for their ability to restore chromatin accessibility and partially reverse age-related immune dysfunctions [81].

Same efforts have focused on senolytics, compounds that selectively eliminate senescent cells, which accumulate with age and secrete pro-inflammatory mediators collectively known as SASP (see above). By reducing the SASP burden, senolytics such as dasatinib and quercetin have demonstrated in animal models the capacity to improve immune function, enhance vaccine responses, and lower infection susceptibility. Early human studies suggest acceptable safety profiles and possible functional benefits, but data on infection outcomes are still preliminary [82].

Although senolytics and epigenetic modulators demonstrate encouraging preclinical effects on immune rejuvenation and infection control, robust clinical data are still sparse. Translational challenges include defining appropriate patient selection, ensuring safety in frail multimorbid populations, and validating long-term efficacy through randomized controlled trials.

Figure 1 shows how multiple biological mechanisms, from immunosenescence and inflammaging to metabolic and epigenetic dysregulation, microbiota shifts, and clinical amplifiers, converge to weaken host defenses in older adults, ultimately heightening their vulnerability to HAIs.